Latest Intelligence on Oncology in Sweden

Select information type

Refine your search

Search tips

Published within

« | 1 | » »|

Type Product title / description Pub Price

AstraZeneca: Arimidex is the new gold standard

The cancer drug showed outstanding results compared to the current gold standard, tamoxifen. Indeed, Arimidex could be the ideal aromatase inhibitor - and judging by these results, AstraZeneca's marketing power will ensure that the drug becomes a major cancer product.

Published By Datamonitor
19 Feb 2002

« | 1 | » »|

No help is available.